Brief: Immune Therapeutics Updates on CEO Search Plans
30/11/2017 15:00
Nov 30 (Reuters) - Immune Therapeutics Inc IMUN.PK :
* IMMUNE THERAPEUTICS INC IMUN.PK SAYS ITS BOARD HAS
APPROVED A
SEARCH FOR A NEW CHIEF EXECUTIVE OFFICER REPLACING NOREEN
GRIFFIN
Source text for Eikon: ID:nPn8lVNm7a
Further company coverage: IMUN.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Biostax
See all newsBrief: Biostax Corp Announces Voluntary Delisting From Otc Pink Market And SEC Deregistration
Brief: Biostax Corp. And Statera Biopharma Inc Reach Mutually Beneficial Dispute Settlement And Amended License Agreement Providing Clearer Clinical And Commercial Pathways For Both Companies
Brief: Immune Therapeutics Inc Announces Management Change
Brief: Statera Biopharma And Immune Therapeutics Inc. Announce Strategic Agreement For Rights To Low Dose Naltrexone
Brief: Immune Therapeutics Today Announces Appointment Of Michael Handley As Its New Chief Executive Officer And Member Of The Board Of Directors